Just days after the U.S. Department of Health and Human Services (HHS) announced the creation of new guidelines designed to increase access to medication-assisted treatment (i.e. buprenorphine) for opioid use disorder, the Biden administration rescinded them. The guidelines, which were issued in the final days of the Trump administration, made it easier for physicians with…

Read More
drug testing

Recently, the U.S. Attorney’s Office for the District of Connecticut, announced an $845 million settlement for a False Claims with a substance abuse provider and a laboratory. The allegations were that a Connecticut substance abuse provider, Crossroads, Inc., submitted excessive urinalysis testing for its patients insured by Connecticut’s Medicaid program. The lab, Secon Laboratories, received…

Read More

A Massachusetts-based electronic health records (EHR) company will pay more than $18 million to resolve allegations that it paid illegal kickbacks to generate sales through its marketing programs. It is the latest in a number of EHR companies under investigation by the U.S. Department of Justice. The complaint alleges that athenahealth Inc. (Athena), violated the…

Read More